Ikarian Capital, LLC Onconova Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.04 - $1.9 $19,734 - $36,052	-18,975 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.46 - $2.82 $5,711 - $11,031	3,912 Added 25.97%	18,975 $35,000
Q3 2021 Nov 15, 2021	SELL	$3.81 - $6.76 $31,101 - $55,181	-8,163 Reduced 35.15%	15,063 $57,000
Q2 2021 Aug 16, 2021	BUY	$6.28 - $16.2 $145,859 - $376,261	23,226 New	23,226 $161,000

276K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.